• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Prophylactic tranexamic acid prevents significant blood loss after cesarean delivery

byBoaz WongandHarsh Shah
May 4, 2021
in Emergency, Obstetrics, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Prophylactic tranexamic acid treatment was shown to lower the incidence of postpartum hemorrhage in women undergoing cesarean delivery.

2. Tranexamic acid treatment was shown not to lower the incidence of hemorrhage-related outcomes such as additional uterotonic agent use and postpartum blood transfusion.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Uterotonic agents are often given to avoid significant postpartum hemorrhage. Tranexamic acid is an antifibrinolytic drug that can help prevent significant blood loss in other elective surgeries and may be applicable to cesarean delivery procedures. As such, this study examined the effect of prophylactic tranexamic acid treatment in women undergoing cesarean delivery. The study determined the patients receiving tranexamic acid experienced a lower incidence of significant postpartum hemorrhage compared to the placebo treatment. With respect to secondary outcomes, no significant differences were found in gravimetrically estimated blood loss, excessive bleeding, or additional interventional measures. However, the tranexamic group had lower estimated blood loss and smaller changes in hemoglobin and hematocrit levels post-surgery. This study boasts a large sample size and small exclusion criteria, suggesting high representativeness to the general population. The study was limited by having included emergency cesarean deliveries performed during labor, which increases the likelihood of postpartum hemorrhage. Nonetheless, the study concluded prophylactic tranexamic acid was effective in preventing significant postpartum hemorrhage after cesarean delivery.

Click to read the study in NEJM

Relevant Reading: Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis

In-Depth [randomized controlled trial]: This randomized control trial enrolled 4,551 women from 27 hospitals in France. Women who were 18 years of age or older, at 34 or more weeks of gestation, and expected to undergo cesarean delivery were included in the study. Women with a history of epilepsy or seizures, increased risk of venous or arterial thrombosis, or poor comprehension of spoken French were excluded from the study. The patients were randomized in a 1:1 ratio to receive either one milligram of tranexamic acid or placebo, respectively. The primary outcome was postpartum hemorrhage, which was defined as a calculated estimated blood loss over 1000mL or administration of red-cell transfusion within two days of delivery. Overall, 26.7% of women receiving tranexamic acid and 31.6% of women in the placebo group experienced postpartum hemorrhage (adjusted risk ratio, 0.84; 95% confidence interval [CI], 0.75 to 0.94; P = 0.003). No significant differences were found between groups in secondary measures of mean gravimetrically estimated blood loss, provider-assessed significant hemorrhage, or incidence of additional related interventions such as emergency surgery or arterial embolization. Finally, women receiving tranexamic acid reported a higher incidence of vomiting or nausea (P < 0.001), but no differences in thromboembolic-related adverse events were found on follow-up three months later (P = 0.08) between both groups. Altogether, prophylactic tranexamic acid was shown to be effective in lowering the incidence of postpartum hemorrhage after cesarean delivery.

RELATED REPORTS

Tranexamic acid decreases postoperative bleeding in non-cardiac surgery patients

Tranexamic acid is unlikely to induce signs suggestive of cerebral ischemia in the treatment of acute intracerebral hemorrhage: TICH-2 study

Early, short-term tranexamic acid does not improve clinical outcomes at 6 months in patients with subarachnoid hemorrhage 

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cesarean deliverypostpartum hemorrhageTranexamic acid
Previous Post

Association between number of teeth and Alzheimer’s Disease risk

Next Post

Childhood fat mass more strongly associated with adult-onset type 2 diabetes risk than childhood weight

RelatedReports

Preoperative tumor embolization does not reduce operative blood loss
Cardiology

Tranexamic acid decreases postoperative bleeding in non-cardiac surgery patients

June 18, 2022
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Emergency

Tranexamic acid is unlikely to induce signs suggestive of cerebral ischemia in the treatment of acute intracerebral hemorrhage: TICH-2 study

March 22, 2022
2 Minute Medicine Rewind June 1 – June 7, 2015
Emergency

Early, short-term tranexamic acid does not improve clinical outcomes at 6 months in patients with subarachnoid hemorrhage 

June 25, 2021
#VisualAbstract: Evolocumab successfully reduced LDL levels in pediatric patients
StudyGraphics

#VisualAbstract: COVID-19 infection in late pregnancy associated with adverse birth outcomes

November 4, 2020
Next Post

Childhood fat mass more strongly associated with adult-onset type 2 diabetes risk than childhood weight

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail

Vadadustat noninferior to darbepoetin for treating anemia in dialysis patients

Food environment associated with gestational diabetes

Younger age of onset of type 2 diabetes linked to higher risk of dementia

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
  • Aspirin thromboprophylaxis noninferior to low-molecular-weight heparin in patients with fractures
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options